Our Mission and Vision

At OneBioLink, our mission is to transform drug discovery by moving beyond traditional animal models to advanced, patient-derived cells and tissues. Our vision is to create a future where drug development is faster, more accurate, and directly relevant to human biology. We are at the forefront of sourcing, developing, and reselling life sciences technologies that bring true human relevance to every stage of drug research.

The Problem

Despite decades of use, animal models do not accurately replicate human physiology. They often fail to predict human responses to new drugs, leading to costly and time-consuming failures in clinical trials.

• Key Stat: Over 90% of drugs that pass animal tests fail in human trials.
• Challenge: Animal models don’t account for the complexities of human biology, leading to inefficiencies and higher risks in drug development.

The OneBioLink Solution: Advanced Patient-Derived Models

At OneBioLink, we harness the power of patient-derived cells and tissues to replace outdated animal models with human-relevant platforms. Our technology leverages advances in cellular biology, tissue engineering, and high-throughput screening to provide more predictive, reliable data earlier in the drug discovery process.

• Advanced Technologies: Proprietary methods for cultivating patient-derived tissues.
• Scientific Expertise: A team of top-tier scientists and industry veterans, combining the latest research with actionable insights.
• Real Human Data: Better predictions of drug efficacy and toxicity through models derived from real patients.